Granulomatosis with Polyangiitis

Rituximab Gains Expanded Approval in Pediatrics

  The Food and Drug Administration has expanded the approval of Rituxan® injection (rituximab) to include the treatment of children ≥2 years of age who have granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), in combination with glucocorticoids. Rituximab is a CD20-directed cytolytic monoclonal antibody first approved in 1997 to…...

Read more

Brandon Hudgins Sets His Sights on U.S. Olympic Team Trials in 2020

Most days, professional distance runner Brandon Hudgins wakes up with a burning desire to reach the goals he’s dreamed of since he was 15 years old. But there have been days when the obstacles seemed insurmountable. At one point, in 2013, he quit running entirely and threw his gear in…...

Read more

Balancing School and Vasculitis: Perspectives from Students and Parents

Lori Larson and son, Matt Being a young adult with vasculitis is challenging enough, but trying to navigate through school while managing the illness demands extraordinary skills. We asked a cross-section of young adult patients (and some parents) how they found the balance between health and academics. “One of the…...

Read more

Creating Vasculitis Awareness in a Remote Corner of Ontario

A personal and professional mission for Dr. Michael Fernando and his wife, Patti Kemp. Michael Fernando, MD, is a family practice and emergency physician who lives and practices medicine in rural southwestern Ontario, Canada. Following medical school in the UK (Bart’s and the London School of Medicine), Dr. Fernando trained…...

Read more

Brandon Hudgins Looks Ahead to New Season of Competitive Racing

Three years ago, professional runner, Brandon Hudgins, beat the challenges from his granulomatosis with polyangiitis (GPA, formerly Wegener’s) to qualify for the 2016 Olympic Trials in the 1500-meter run. Although he didn’t make the Olympic team, Brandon hasn’t lost his determination to race competitively and is keeping a hopeful eye…...

Read more